Oncolytic virotherapy for prevention of tumor recurrence

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9861669
SERIAL NO

13376137

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described is a parvovirus for preventing recurrence of a tumor, preferably a malignant brain tumor or pancreas tumor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTSIM NEUENHEIMER FELD 280 HEIDELBERG 69120
RUPRECHT-KARLS-UNIVERSITAET HEIDELBERGGRABENGASSE 1 HEIDELBERG D-69117

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aprahamian, Marc Limersheim, FR 8 15
Geletneky, Karsten Heidelberg, DE 15 44
Grekova, Svitlana Heidelberg, DE 4 5
Kiprijanova, Irina Heidelberg, DE 5 17
Koch, Ute Epalinges, CH 1 3
Raykov, Zahari Heidelberg, DE 9 17
Rommelaere, Jean Heidelberg, DE 48 78

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 9, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 9, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00